M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Shen, Long ^a   Li, Honghao ^a   Shi, Yuzhi ^a   Wang, Dekun ^a   Gong, Junbo ^b   Xun, Jing ^a   Zhou, Sifan ^a   Xiang, Rong ^a   Tan, Xiaoyue ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 1; CYSTEINE PROTEINASE; FIBRONECTIN; LEGUMAIN;

ANIMAL; DIFFUSE LARGE B CELL LYMPHOMA; DISEASE EXACERBATION; DISEASE MODEL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MACROPHAGE; METABOLISM; MORTALITY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; XENOGRAFT;

ANIMALS; BIOMARKERS; COLLAGEN TYPE I; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FIBRONECTINS; GENE EXPRESSION; HETEROGRAFTS; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE B-CELL, DIFFUSE; MACROPHAGES; MICE; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 84979950751     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30347     Document Type: Article

References (34)

1. Lenz, G., Staudt, L. M. Aggressive lymphomas. The New England journal of medicine 362, 1417-1429, doi: 10.1056/NEJMra0807082 (2010).
2. Liu, C., Sun, C. Z., Huang, H. N., Janda, K., Edgington, T. Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. Cancer Res. 63, 2957-2964 (2003).
3. Lenz, G. et al. Stromal gene signatures in large-B-cell lymphomas. The New England journal of medicine 359, 2313-2323, doi: 10.1056/NEJMoa0802885 (2008).
4. Martin-Moreno, A. M. et al. CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma. Plos one 10, e0125203, doi: 10.1371/journal.pone.0125203 (2015).
5. Wang, H. et al. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type. Annals of hematology 94, 1535-1544, doi: 10.1007/s00277-015-2401-4 (2015).
6. Wang, X. et al. Toll-like receptor 4-induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphoma. Annals of diagnostic pathology 19, 232-238, doi: 10.1016/j. anndiagpath.2015.04.008 (2015).
7. Condeelis, J., Pollard, J. W. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266, doi: 10.1016/j.cell.2006.01.007 (2006).
8. Qian, B. Z., Pollard, J. W. Macrophage Diversity Enhances Tumor Progression and Metastasis. Cell 141, 39-51, doi: 10.1016/j. cell.2010.03.014 (2010).
9. Kurahara, H. et al. Significance of M2-Polarized Tumor-Associated Macrophage in Pancreatic Cancer. J Surg Res. 167, E211-E219, doi: 10.1016/j.jss.2009.05.026 (2011).
10. Niino, D. et al. Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL). Pathology international 60, 278-283, doi: 10.1111/j.1440-1827.2010.02514.x (2010).
11. Hasselblom, S. et al. Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis. Pathology international 58, 529-532, doi: 10.1111/j.1440-1827.2008.02268.x (2008).
12. Komohara, Y., Niino, D., Ohnishi, K., Ohshima, K., Takeya, M. Role of tumor-associated macrophages in hematological malignancies. Pathology international 65, 170-176, doi: 10.1111/pin.12259 (2015).
13. Liu, C., Sun, C., Huang, H., Janda, K., Edgington, T. Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. Cancer Res. 63, 2957-2964 (2003).
14. Luo, Y. et al. Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest. 116, 2132-2141, doi: 10.1172/JCI27648 (2006).
15. Lewen, S. et al. A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis. Cancer immunology, immunotherapy : CII 57, 507-515, doi: 10.1007/s00262-007-0389-x (2008).
16. Dall, E., Brandstetter, H. Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation. Proceedings of the National Academy of Sciences of the United States of America 110, 10940-10945, doi: 10.1073/pnas.1300686110 (2013).
17. Lin, Y. et al. Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis. Cancer science 104, 1217-1225, doi: 10.1111/cas.12202 (2013).
18. Gautam, P. K., Acharya, A. Antigenic Hsp70-peptide upregulate altered cell surface MHC class I expression in TAMs and increases anti-tumor function in Dalton's lymphoma bearing mice. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 36, 2023-2032, doi: 10.1007/s13277-014-2809-9 (2015).
19. Ekici, O. D. et al. Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases. Journal of medicinal chemistry 47, 1889-1892, doi: 10.1021/jm049938j (2004).
20. Zameer, M. A., Premalata, C. S., Arunakumari, B., Appaji, L., Rao, C. R. Pediatric Hodgkin lymphoma in a South Indian regional cancer center: its immunomorphology, tumor-associated macrophages, and association with Epstein-Barr virus. Pediatric hematology and oncology 32, 229-238, doi: 10.3109/08880018.2014.954071 (2015).
21. Saito, Y. et al. Role of CD204-positive tumor-associated macrophages in adult T-cell leukemia/lymphoma. Journal of clinical and experimental hematopathology : JCEH 54, 59-65 (2014).
22. Jones, K. et al. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 19, 731-742, doi: 10.1158/1078-0432.CCR-12-2693 (2013).
23. Zhou, L., Yang, K., Andl, T., Wickett, R. R., Zhang, Y. Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma. Journal of Cancer 6, 717-726, doi: 10.7150/jca.10865 (2015).
24. Leeming, D. J. et al. Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 16, 193-205, doi: 10.3109/1354750X.2011.557440 (2011).
25. Liu, Z. et al. Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment. Nature communications 5, 4280, doi: 10.1038/ncomms5280 (2014).
26. Lin, Y. et al. Functional role of asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion and metastasis. Journal of the National Cancer Institute 106, dju012, doi: 10.1093/jnci/dju012 (2014).
27. Fonovic, M., Turk, B. Cysteine cathepsins and extracellular matrix degradation. Biochimica et biophysica acta 1840, 2560-2570, doi: 10.1016/j.bbagen.2014.03.017 (2014).
28. Lee, J., Bogyo, M. Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain. Bioorganic & medicinal chemistry letters 22, 1340-1343, doi: 10.1016/j.bmcl.2011.12.079 (2012).
29. Ohshima, K. et al. Exosome-mediated extracellular release of polyadenylate-binding protein 1 in human metastatic duodenal cancer cells. Proteomics 14, 2297-2306, doi: 10.1002/pmic.201300477 (2014).
30. Mu, W., Rana, S., Zoller, M. Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia 15, 875-887 (2013).
31. Panico, L. et al. High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages. Leukemia & lymphoma 56, 1636-1642, doi: 10.3109/10428194.2014.951849 (2015).
32. Kumagai, S. et al. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma. Lung Cancer 85, 457-464, doi: 10.1016/j.lungcan.2014.06.015 (2014).
33. Shen, L. et al. Overexpression of Oct4 suppresses the metastatic potential of breast cancer cells via Rnd1 downregulation. Biochimica et biophysica acta 1842, 2087-2095, doi: 10.1016/j.bbadis.2014.07.015 (2014).
34. Liu, Y. et al. FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS. Nature medicine 20, 272-282, doi: 10.1038/nm.3485 (2014).